General Annual Meeting 2012
Friday 27 - Saturday 28 January 2012 - Palais des Congrès, Liège
Abstracts oral / poster presentations
BHS Board 2011 annual report (2.0 Mb)
Oral / Poster Awards during the GAM 2012
Oral presentation award
- Els Lierman (Leuven), "Ponatinib is active against imatinib resistant mutants of FIP1L1-PDGFRA and KIT, and against FGFR1-derived fusion kinases"
- Nathalie Nols (Yvoir), "Quantitative and qualitative analysis of metabolic response at interim FDG pet-scan is highly predictive of outcome in diffuse large B-cell lymphoma (DLBCL)"
Poster presentation award
- Marilène Binsfeld (Liège), "Adaptation of a murine chronic GVH model to study graft versus myeloma effect after allogeneic transplantation"
- Farganeh Ghazavi (Gent), "Improved risk-stratification and outcome prediction in children with average risk precursor-B acute lymphoblastic leukemia using a nineteen -microRNA signature"
- Sylvia Snauwaert (Gent), "Evaluation of the Receptor for Hyaluronic Acid Mediated Motility (RHAMM) as a tumor specific antigen in AML"
- Karolien Beel (Antwerp), "Gain-of-function WAS mutations lead to a disorganized actin cytoskeleton and loss of cell orientation"
Accreditation: Activity n° 11026730, Category 3, 9.5 CP
Slides invited speakers:
Treatment of relapsed DLBCL - C. Gisselbrecht (Paris, France) Treatment of relapsed Hodgkin's lymphom - P. Borchman (Koln, Germany) Recent advances in Severe Combined Immune Deficiency - L. Notarangelo (Boston, USA) Regulation of Hematopoietic Stem Cells and their bone-Marrow Niches by the Coagulation System - T. Lapidot (Rehovot, Israel)
Stem Cell Plasticiy - P. Vanderhaeghen (Brussels) [not available for publication] Classification and prognosis of MDS - U. Germing (Dusseldorf, Germany) Treatment of MDS - P. Fenaux (Lille, France) MDS in children - C. Niemeyer (Freiburg, Germany)